3 ms·
As the article says, this immunotherapy essentially works by turning off some of the immune system's "don't attack your own body" safeties. This frees the immun
by pflats 7y ago
As the article says, this immunotherapy essentially works by turning off some of the immune system's "don't attack your own body" safeties. This frees the immune system to attack the cancer (provided it can identify it).
One big advantage of immunotherapy is that the therapy causes a long-term (permanent? I'm not sure anyone knows; the drugs are less than a decade old) change to the immune system - the body continues to attack the cancer even after the drug treatment has ceased.
If you put these two things together, however, you might see why the side effects can be so bizarre. Your immune system might decide that the liver looked at it funny one day, but then decide that the GI tract is actually the real troublemaker a few days later. And since the immune system change persists post-treatment, so do the side effects.
These side effects can (usually) be controlled with corticosteroids (hydrocortisone/prednisone/etc.), which have an immunosuppressant effect. Of course, long-term corticosteroid use has its own severe side effects (plus severe dependency issues). And if you're suppressing the immune system, then you're suppressing the mechanism that the immunotherapy uses to fight the cancer in the first place. The treatment and the side effects are two sides of the same coin.
- metiscus 7y agoThis video is an excellent presentation on the subject by Dr. Allison. https://youtu.be/r1Fp6C1xx6Q https://youtu.be/r1Fp6C1xx6Q
- klipt 7y ago> this immunotherapy essentially works by turning off some of the immune system's "don't attack your own body" safeties That sounds like checkpoint inhibitor immunotherapy. Others like CAR-T may have fewer side effects, since they're just augmenting your T cells with a manufactured supply that is primed to attack a specific target. CAR-T is a lot more expensive for now but over time such "precision" immunotherapies may become mass produced and cheaper and we'll be able to make the immune system do what we want with fewer side effects.
- pflats 7y ago> That sounds like checkpoint inhibitor immunotherapy. You are correct. That is because the article is about checkpoint inhibitor immunotherapy (specifically yervoy/ipilimumab and opdivo/nivolumab).
- deleted 7y ago[deleted]